[TVTX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
20-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 60.00%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 145,238 212,018 227,490 198,321 175,338 164,246 154,937 -1.07%
PBT -376,110 -278,169 -179,682 -188,790 -146,448 -101,867 -58,363 36.39%
Tax 223 313 409 -19,359 -21 811 1,368 -26.07%
NP -111,399 -278,482 -180,091 -169,431 -146,427 -102,678 -59,731 10.94%
Tax Rate - - - - - - - -
Total Cost 256,637 490,500 407,581 367,752 321,765 266,924 214,668 3.01%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -76.70 -131.35 -79.16 -85.43 -83.51 -62.51 -38.55 12.14%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.50 -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -0.43%
EPS Diluted -1.50 -4.37 -3.01 -3.56 -3.46 -2.54 -1.54 -0.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.